Literature DB >> 14969612

Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable angina pectoris.

Parag B Patel1, Steven E Pfau, Michael W Cleman, Joseph J Brennan, Christopher Howes, Michael Remetz, Henry S Cabin, John F Setaro, Henry M Rinder.   

Abstract

This study evaluates transcoronary changes in neutrophil and platelet activation and conjugate formation in patients with angina pectoris secondary to coronary artery disease. We examined parameters of neutrophil and platelet activation as well as the neutrophil-platelet conjugate formation in patients who underwent diagnostic coronary angiography. Thirty-nine patients with chest pain referred for cardiac catheterization were studied (23 patients with unstable angina pectoris [UAP] and 16 with stable angina pectoris [SAP]). Before coronary angiography, blood samples were obtained simultaneously from the aortic root and coronary sinus to assess leukocyte (CD11b) and platelet (CD62P) activation and leukocyte-platelet conjugates. There was a 94% increase in CD62-expressing platelets from the aorta to the coronary sinus in patients with UAP compared with a 49% increase in patients with SAP. The percentage of neutrophil-platelet conjugates increased by 22% in patients with UAP compared with a 16% decrease in those with SAP (p <0.01). In contrast, monocyte-platelet binding across the coronary bed increased to a similar degree in both groups. This study demonstrates an increase in neutrophil-platelet conjugates across the coronary circulation in UAP, compatible with a higher activation state in both cell types.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14969612     DOI: 10.1016/j.amjcard.2003.10.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina.

Authors:  Satoshi Murasaki; Kagari Murasaki; Kenjiro Tanoue; Masatoshi Kawana; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

2.  Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease.

Authors:  Valter Lubrano; Franca Cocci; Debora Battaglia; Angela Papa; Paolo Marraccini; Gian Carlo Zucchelli
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  Lipoxin A₄ inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression.

Authors:  Emma Börgeson; Johanna Lönn; Ida Bergström; Veronika Patcha Brodin; Sofia Ramström; Fariba Nayeri; Eva Särndahl; Torbjörn Bengtsson
Journal:  Infect Immun       Date:  2011-01-24       Impact factor: 3.441

4.  Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease.

Authors:  Nikolaos Kafkas; Christos Demponeras; Filitsa Zoubouloglou; Loukia Spanou; Dimitrios Babalis; Konstantinos Makris
Journal:  Int J Inflam       Date:  2012-09-04

5.  Neutrophil activation status in stable coronary artery disease.

Authors:  Eva Särndahl; Ida Bergström; Veronika Patcha Brodin; Johnny Nijm; Helen Lundqvist Setterud; Lena Jonasson
Journal:  PLoS One       Date:  2007-10-24       Impact factor: 3.240

Review 6.  Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products.

Authors:  Eduardo Fuentes; Iván Palomo
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-13       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.